Heat Biologics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

You can watch Heat Biologics and buy or sell other stocks, options, and ETFs commission-free!

About HTBX

NightHawk Biosciences, Inc. is a clinical stage company, which engages in the development of immunotherapies designed to activate and expand a patient's T-cell mediated immune system against cancer. The company's T-cell activating platform (TCAP) produces therapies designed to turn immunologically cold tumors to hot, and be administered in combination with checkpoint inhibitors and other immuno-modulators to increase clinical effectiveness. 

CEO
Jeff A. Wolf, MBA
CEOJeff A. Wolf, MBA
Employees
49
Employees49
Headquarters
Morrisville, North Carolina
HeadquartersMorrisville, North Carolina
Founded
2008
Founded2008
Employees
49
Employees49

HTBX Key Statistics

Market cap
44.37M
Market cap44.37M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
69.81K
Average volume69.81K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$6.09
52 Week high$6.09
52 Week low
$1.60
52 Week low$1.60

HTBX Earnings

-$0.06
-$0.04
-$0.02
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
per share
Estimated per share
Actual
Expected May 5, After Hours
ActualExpected May 5, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.